GSK sees China as its most important strategic market

06/20/2004 | China Daily (Beijing)

GlaxoSmithKline anticipates China will be its most important strategic market for the next 10 years. A senior GSK executive said GSK China achieved the third highest growth rate of all GSK companies, and it is estimated the Chinese medical market will be worth $14 billion by 2006 and $24 billion by 2010. GSK has already invested in five factory sites in the country and is moving more work there to maximize its resources.

View Full Article in:

China Daily (Beijing)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC